Dr Bernard Sissolak is Head of Innovation/Pharma at Bilfinger Life Science and is dedicated to make continuous bioprocessing work. In 2019 he launched the integrated continuous manufacturing project called “end2end. Since then, his team has to face the challenges of establishing an integrated, truly continuous and fully automated process skid for the production of biopharmaceuticals.